You are here

obesity

Arrowhead commences dosing in Phase I/IIa obesity treatment trial

Clinical Trials Arena

Tue, 06/3/25 - 11:34 am

Arrowhead Pharmaceuticals

clinical trials

Wegovy use up 50% among US teens

Yahoo/Reuters

Tue, 06/3/25 - 11:12 am

Regeneron's weight-loss drug combo helps preserve muscle in study

MSN/Reuters

Tue, 06/3/25 - 10:43 am

clinical trials

Regeneron pens $2B pact for Hansoh's potential obesity rival to Lilly's Zepbound

Fierce Biotech

Mon, 06/2/25 - 11:17 am

The MAHA agenda won’t include expanding GLP-1 coverage — for now

Pharma Voice

Mon, 06/2/25 - 11:13 am

Robert F Kennedy Jr.

Muscle-sparing obesity drug safe for Phase 3 trial, Veru says

BioPharma Dive

Wed, 05/28/25 - 10:58 pm

clinical trials

GLP-1 prescriptions for weight loss soar, despite obstacles

BioPharma Dive

Wed, 05/28/25 - 10:58 am

Did Eli Lilly Just Say Checkmate to Novo Nordisk?

Motley Fool

Thu, 05/22/25 - 11:40 am

As Eli Lilly outperforms Novo in market, it also replaces its rival in annual IDEA Innovation rankings

Fierce Pharma

Wed, 05/21/25 - 11:53 am

Lilly’s former small molecule head makes the leap to a rising biotech in obesity

Pharma Voice

Wed, 05/21/25 - 11:07 am

Weight loss drugs have "no end game" amid lack of data on long-term use, former FDA commissioner warns

CBS News

Thu, 05/15/25 - 10:47 am

Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs

Fierce Biotech

Wed, 05/14/25 - 10:56 am

Roche plans $700m manufacturing plant in the US

Yahoo Finance

Mon, 05/12/25 - 09:49 pm

drug manufacturing

Novo’s Wegovy inches closer to becoming first FDA-approved GLP-1 weight-loss pill

BioSpace

Mon, 05/5/25 - 11:29 am

Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday

Motley Fool

Sun, 05/4/25 - 12:09 pm

Viking Therapeutics

FDA frees Amgen's phase 1 obesity asset from clinical trial hold

Fierce Biotech

Fri, 05/2/25 - 11:18 am

clinical trials

WHO set to back use of weight-loss drugs for adults globally, raises cost issue

MSN/Reuters

Thu, 05/1/25 - 10:28 pm

CVS to boost access to Novo Nordisk’s weight loss treatment Wegovy for patients on its drug plans

CNBC

Thu, 05/1/25 - 11:10 am

Will Pfizer Acquire Altimmune or Viking Therapeutics After Its Obesity Pill Setback?

Motley Fool

Wed, 04/30/25 - 11:00 am

Viking Therapeutics

Novo Nordisk opens weight loss drug Wegovy to telehealth; Hims & Hers shares rocket 40%

CNBC

Tue, 04/29/25 - 08:23 am

Hims & Hers Health

Pages